GSA CAPITAL PARTNERS LLP - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 94 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$159
-69.7%
1,275,215
-75.0%
0.02%
-75.4%
Q4 2022$525
-99.9%
5,095,354
-2.4%
0.06%
-38.1%
Q3 2022$794,000
+556.2%
5,222,292
+3686.0%
0.10%
+483.3%
Q2 2022$121,000
+31.5%
137,938
+86.5%
0.02%
+50.0%
Q1 2022$92,000
+4.5%
73,969
+131.3%
0.01%
+33.3%
Q3 2021$88,00031,9840.01%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders